Early Access Programmes Europe
Date: | 12-Oct-15 to 14-Oct-15 |
Location: | London, UK / London / United Kingdom |
Category: | Healthcare & Pharmaceuticals Science Conferences & Trade Fairs |
The pharmaceutical and biotechnology pipeline has become much more specialty focused, with more and more drugs treating rare diseases now going through into main development.
In order to meet the demand for these investigational drugs and ensure an equitable supply, sponsor companies are tasked with accurately anticipating demand and strategically planning to ensure they can successfully implement and execute these early access programmes.
In addition, country-specific regulatory requirements, safety data and sufficient resources are major concerns that impact industry’s decision to run these programmes.
Pharma IQ’s Early Access Programmes Europe provides a platform to address and gain clarity of the complexities that surround EAPs.
The event features 20+ speakers from pharmaceutical and biotechnology companies as well as regulatory authorities, patient advocated and HCPS.
BUILD ON EXPERIENCES AND DEVELOP BEST PRACTICE TO OVERCOME THE CHALLENGES OF:
Understanding the types of early access programmes available and the different country regulations
Anticipating demand and make the determination to run an EAP: risk vs benefit, safety data, resources and stakeholder engagement
Developing an effective planning strategy to forecast and establish accurate drug supply
Ensuring equitable drug supply allocation
Successfully implementing, monitoring and closing out an EAP
Understanding the patient perspective and utilising independent bodies to facilitate and support EAPs
Join industry experts across Europe and the USA for three influential days of discussions that will give clarity on regulatory complexities and the challenges faced by sponsor companies.
Take advantage of this opportunity to share experiences, build on successful strategies and develop best practices.
P.S. Take a look at our resource centre to download brand new interviews with Jose Ricardo Perez, Novartis Oncology, and Kennith Moch, Former CEO at Chimerix.
In order to meet the demand for these investigational drugs and ensure an equitable supply, sponsor companies are tasked with accurately anticipating demand and strategically planning to ensure they can successfully implement and execute these early access programmes.
In addition, country-specific regulatory requirements, safety data and sufficient resources are major concerns that impact industry’s decision to run these programmes.
Pharma IQ’s Early Access Programmes Europe provides a platform to address and gain clarity of the complexities that surround EAPs.
The event features 20+ speakers from pharmaceutical and biotechnology companies as well as regulatory authorities, patient advocated and HCPS.
BUILD ON EXPERIENCES AND DEVELOP BEST PRACTICE TO OVERCOME THE CHALLENGES OF:
Understanding the types of early access programmes available and the different country regulations
Anticipating demand and make the determination to run an EAP: risk vs benefit, safety data, resources and stakeholder engagement
Developing an effective planning strategy to forecast and establish accurate drug supply
Ensuring equitable drug supply allocation
Successfully implementing, monitoring and closing out an EAP
Understanding the patient perspective and utilising independent bodies to facilitate and support EAPs
Join industry experts across Europe and the USA for three influential days of discussions that will give clarity on regulatory complexities and the challenges faced by sponsor companies.
Take advantage of this opportunity to share experiences, build on successful strategies and develop best practices.
P.S. Take a look at our resource centre to download brand new interviews with Jose Ricardo Perez, Novartis Oncology, and Kennith Moch, Former CEO at Chimerix.
Exhibitors
Anne Cropp, Vice President, Pfizer, Ramana Sonty, Director, Global Medical Organisation, Johnson & Johnson, Carlos Camozzi, Chief Medical Officer, Orphazyme, Paresh Sewpaul, Global Medical Affairs Director, Haem-Oncology Novartis, And Many More....
EIN News
provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See:
- Autism News Today
- Brain Cancer News Today
- Breast Cancer News Today
- Breastfeeding News Today
- CNES News Today
- Canadian Space Agency News Today
- Conferences & Trade Shows Today
- Dental Industry Today
- Dietary Supplements News Today
- H1N1 News Today
- H7N9 Bird Flu News Today
- Health Insurance Exchanges News
- Healthcare Industry Today
- Healthcare Reform News Today
- Home Birth News Today
- JAXA News Today
- Lung Cancer News Today
- MERS News Today
- Malaria News Today
- Marijuana News Today
- Mesothelioma News Today
- NASA News Today
- Pharmaceutical Industry Today
- Planned Parenthood News Today
- Prostate Cancer News Today
- Research Reports News Today
- SARS News Today
- Science News Today
- Wellness News Today